Results 201 to 210 of about 13,061,190 (344)

Factor VIII Activity and Factor VIII Inhibitors Can Be Measured Accurately in Plasma Containing Mim8 by Using Specific Chromogenic Assays. [PDF]

Haemophilia
Pickering W, Robinson M, Cogswell C, Clausen WHO, Weldingh KN, Ezban M.   +5 more
europepmc   +1 more source

Enhancing the pharmacokinetic properties of recombinant factor VIII: first‐in‐human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A

Journal of Thrombosis and Haemostasis, 2013
A. Tiede, B. Brand, R. Fischer, K. Kavaklı, S. Lentz, T. Matsushita, C. Rea, K. Knobe, D. Viuff   +8 more
semanticscholar   +1 more source

Adult‐Onset Subacute Sclerosing Panencephalitis Presenting With Subacute Cognitive Deficits

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT We describe the case of a 41‐year‐old man diagnosed with adult‐onset subacute sclerosing panencephalitis (SSPE). The patient presented with subacute progressive cognitive deficits and a neuropsychological profile indicating predominant frontoparietal dysfunction. MRI showed only mild parietal‐predominant cerebral atrophy.
Dennis Yeow, Nicola McKern, Vincent Oxenham, Kate Ahmad, Omar Ahmad   +4 more
wiley   +1 more source

Loss of factor VIII in zebrafish rebalances antithrombin deficiency but has a limited bleeding diathesis. [PDF]

Blood Adv
Raghunath A, Richter CE, Griffin MS, Emly SM, Yaman M, Arruda VR, Samelson-Jones BJ, Shavit JA.   +7 more
europepmc   +1 more source

Factor VIII-von Willebrand factor requires calcium for facilitation of platelet adherence [PDF]

, 1984
KS Sakariassen, M Ottenhof-Rovers, JJ Sixma   +2 more
openalex   +1 more source

Factor VIII inhibitors in hemophilia A: rationale and latest evidence

Therapeutic Advances in Hematology, 2013
C. Witmer, G. Young
semanticscholar   +1 more source

Shared Genetic Effects and Antagonistic Pleiotropy Between Multiple Sclerosis and Common Cancers

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Epidemiologic studies have reported inconsistent altered cancer risk in individuals with multiple sclerosis (MS). Factors such as immune dysregulation, comorbidities, and disease‐modifying therapies may contribute to this variability.
Asli Buyukkurt, Marius Ygonia, Ali Manouchehrinia, Philippe Lefrançois, Ingrid Kockum, Adil Harroud   +5 more
wiley   +1 more source

Enzymatic degradation of the factor-VIII-von-Willebrand protein: a unique tryptic fragment with ristocetin cofactor activity [PDF]

, 1980
SE Martin, VJ Marder, CW Francis, LS Loftus, GH Barlow   +4 more
openalex   +1 more source

Randomized, controlled, parallel‐group trial of routine prophylaxis vs. on‐demand treatment with sucrose‐formulated recombinant factor VIII in adults with severe hemophilia A (SPINART)

Journal of Thrombosis and Haemostasis, 2013
M. Manco‐Johnson, C. Kempton, M. Reding, T. Lissitchkov, S. Goranov, L. Gercheva, L. Rusen, M. Ghinea, V. Uscăţescu, V. Rescia, W. Hong   +10 more
semanticscholar   +1 more source

Real‐World Performance of CSF Kappa Free Light Chains in the 2024 McDonald Criteria

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Kappa free light chains (KFLCs) in the cerebrospinal fluid (CSF) have a similar performance to CSF‐restricted oligoclonal bands (OCB) for multiple sclerosis (MS) diagnosis. To help with implementation, we set out to resolve several remaining uncertainties: (1) performance in a real‐world cohort and the 2024 McDonald criteria; (2 ...
Maya M. Leibowitz, Ryan Cooper, Stefania Kaninia, Kathryn I. Challis, Will Greenway, Maria Bonello, Mahmoud Elbahnasawi, Deborah T. Shode, Dominika Gajdasik, Victor Iliev, Alison M. E. Whitelegg, Ian Galea   +11 more
wiley   +1 more source